Spyridoula Vasileiou

3PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 02, 2026
Autologous multiantigen-targeted T cell therapy for pancreatic cancer: a phase 1/2 trial.

Benjamin L Musher, Spyridoula Vasileiou, Brandon G Smaglo

|Jan 10, 2025
Molecular dynamics at immune synapse lipid rafts influence the cytolytic behavior of CAR T cells.

Ahmed Z Gad, Jessica S Morris, Lea Godret-Miertschin

|Jan 28, 2021
T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects.

Spyridoula Vasileiou, Premal D Lulla, Ifigeneia Tzannou

Pageof 1